Edwards Lifesciences (EW)

About Edwards Lifesciences (EW)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Details

Daily high

$84.60

Daily low

$83.64

Price at open

$84.35

52 Week High

$87.89

52 Week Low

$65.94

Market cap

48.7B

Dividend yield

0.00%

Volume

2.1M

Avg. volume

3.5M

P/E ratio

35.73

Edwards Lifesciences News